These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35387046)

  • 1. Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy.
    McSweeney MD; Mohan M; Commins SP; Lai SK
    Front Allergy; 2021; 2():715844. PubMed ID: 35387046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis.
    Li DH; Lee E; Song C
    Allergy Asthma Clin Immunol; 2022 Jun; 18(1):57. PubMed ID: 35725661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
    Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.
    Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S
    Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
    Zhou ZH; Cortese MM; Fang JL; Wood R; Hummell DS; Risma KA; Norton AE; KuKuruga M; Kirshner S; Rabin RL; Agarabi C; Staat MA; Halasa N; Ware RE; Stahl A; McMahon M; Browning P; Maniatis P; Bolcen S; Edwards KM; Su JR; Dharmarajan S; Forshee R; Broder KR; Anderson S; Kozlowski S
    Vaccine; 2023 Jun; 41(28):4183-4189. PubMed ID: 37244808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy.
    Cha B; Kwon KS; Lee HL; Kim CW
    J Korean Med Sci; 2022 Aug; 37(32):e251. PubMed ID: 35971765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy.
    Broos N; Brigitha LJ; Schuurhof A; Röckmann-Helmbach H; Tissing WJE; Pieters R; van der Sluis IM; Stadermann MB
    EJC Paediatr Oncol; 2023; 1():100002. PubMed ID: 38013843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.
    Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC
    JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
    Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
    J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.
    Barbaud A; Garvey LH; Arcolaci A; Brockow K; Mori F; Mayorga C; Bonadonna P; Atanaskovic-Markovic M; Moral L; Zanoni G; Pagani M; Soria A; Jošt M; Caubet JC; Carmo A; Mona AA; Alvarez-Perea A; Bavbek S; Benedetta B; Bilo MB; Blanca-López N; Bogas HG; Buonomo A; Calogiuri G; Carli G; Cernadas J; Cortellini G; Celik G; Demir S; Doña I; Dursun AB; Eberlein B; Faria E; Fernandes B; Garcez T; Garcia-Nunez I; Gawlik R; Gelincik A; Gomes E; Gooi JHC; Grosber M; Gülen T; Hacard F; Hoarau C; Janson C; Johnston SL; Joerg L; Kepil Özdemir S; Klimek L; Košnik M; Kowalski ML; Kuyucu S; Kvedariene V; Laguna JJ; Lombardo C; Marinho S; Merk H; Meucci E; Morisset M; Munoz-Cano R; Murzilli F; Nakonechna A; Popescu FD; Porebski G; Radice A; Regateiro FS; Röckmann H; Romano A; Sargur R; Sastre J; Scherer Hofmeier K; Sedláčková L; Sobotkova M; Terreehorst I; Treudler R; Walusiak-Skorupa J; Wedi B; Wöhrl S; Zidarn M; Zuberbier T; Agache I; Torres MJ
    Allergy; 2022 Aug; 77(8):2292-2312. PubMed ID: 35112371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allergy to Pfizer-BioNTech® vaccine demonstrated by skin testing].
    Estrada-García CD; Macías-Robles AP; Cortés-Grimaldo RM; Carvajal-Alonso HL; Barreto-Alcalá M; Ramírez-Nepomuceno A; Esparza-Amaya D; Coronado-Hernández KG; Barrios-Díaz B; Campos-Téllez HH
    Rev Alerg Mex; 2023 Jan; 69(2):89-92. PubMed ID: 36928249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.
    Brockow K; Mathes S; Fischer J; Volc S; Darsow U; Eberlein B; Biedermann T
    Allergy; 2022 Jul; 77(7):2200-2210. PubMed ID: 34806775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 mRNA vaccine allergy.
    Risma KA
    Curr Opin Pediatr; 2021 Dec; 33(6):610-617. PubMed ID: 34670264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract.
    Gaspar A; Moura AL; Cruz C; Borrego LM
    Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):261-270. PubMed ID: 36458507
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose.
    AlMuhizi F; Ton-Leclerc S; Fein M; Tsoukas C; Garvey LH; Lee D; Ben-Shoshan M; Isabwe GAC; Copaescu AM
    Front Allergy; 2022; 3():825164. PubMed ID: 35386647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.
    Kozma GT; Mészáros T; Berényi P; Facskó R; Patkó Z; Oláh CZ; Nagy A; Fülöp TG; Glatter KA; Radovits T; Merkely B; Szebeni J
    Vaccine; 2023 Jul; 41(31):4561-4570. PubMed ID: 37330369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine).
    Bavli Y; Chen BM; Gross G; Hershko A; Turjeman K; Roffler S; Barenholz Y
    J Control Release; 2023 Feb; 354():316-322. PubMed ID: 36549393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.
    Khalid MB; Frischmeyer-Guerrerio PA
    J Allergy Clin Immunol Glob; 2023 Feb; 2(1):1-13. PubMed ID: 36532656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated liposomes for diagnosis of polyethylene glycol allergy.
    Perkins GB; Tunbridge MJ; Hurtado PR; Zuiani J; Mhatre S; Yip KH; Le TA; Yuson C; Kette F; Hissaria P
    J Allergy Clin Immunol; 2024 May; ():. PubMed ID: 38718949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.